Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VENATORX PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2019-07-17 to 2025-09-30
Current total value of award: $125372213
Description: THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE SUPPLEMENTAL FUNDING FOR CLIN0002, AND CLIN0003, EXTEND THE PERIOD OF PERFORMANCE FOR CLIN0002 THROUGH MARCH 31, 2024, EXTEND THE PERIOD OF PERFORMANCE FOR CLIN0003 THROUGH SEPTEMBER 30, 2025, AND INCORP